SCHIFFER, Davide
 Distribuzione geografica
Continente #
NA - Nord America 4.689
EU - Europa 4.095
AS - Asia 1.439
AF - Africa 35
SA - Sud America 18
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.291
Nazione #
US - Stati Uniti d'America 4.512
CN - Cina 948
IT - Italia 673
IE - Irlanda 557
SE - Svezia 491
UA - Ucraina 487
FR - Francia 404
DE - Germania 397
GB - Regno Unito 295
FI - Finlandia 258
KR - Corea 225
AT - Austria 155
CA - Canada 143
PL - Polonia 141
DK - Danimarca 124
VN - Vietnam 88
IN - India 55
MX - Messico 33
SN - Senegal 25
JP - Giappone 23
TW - Taiwan 22
NL - Olanda 18
BE - Belgio 17
SG - Singapore 17
CH - Svizzera 16
RU - Federazione Russa 16
BR - Brasile 15
GR - Grecia 13
HK - Hong Kong 13
TR - Turchia 12
AU - Australia 9
ES - Italia 9
IR - Iran 8
UZ - Uzbekistan 8
ID - Indonesia 7
MU - Mauritius 7
PT - Portogallo 6
HU - Ungheria 4
RO - Romania 4
NZ - Nuova Zelanda 3
PK - Pakistan 3
CZ - Repubblica Ceca 2
EU - Europa 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
PH - Filippine 2
SA - Arabia Saudita 2
AP - ???statistics.table.value.countryCode.AP??? 1
AR - Argentina 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
SI - Slovenia 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 10.291
Città #
Beijing 691
Chandler 650
Dublin 555
Jacksonville 268
Villeurbanne 250
Ann Arbor 237
Houston 218
Ashburn 200
Medford 196
Princeton 192
Fairfield 182
Vienna 154
Torino 146
Wilmington 143
Woodbridge 138
Dearborn 131
Nyköping 131
Warsaw 130
Milan 102
Toronto 88
Frankfurt am Main 84
Boardman 80
Seattle 72
Fremont 67
Pisa 59
Boston 56
Dong Ket 55
Verona 54
Redwood City 51
Cambridge 41
Lachine 32
Guangzhou 22
Norwalk 22
Falls Church 19
Rome 19
London 18
Nanjing 16
San Antonio 16
Jinan 15
Taipei 15
Brussels 14
Chengdu 14
Hefei 14
Los Angeles 14
New York 14
Shanghai 14
Hangzhou 13
Kunming 12
Mountain View 12
Turin 12
Xian 12
Auburn Hills 11
Washington 10
Athens 9
Düsseldorf 9
Mexico City 9
Munich 9
Ottawa 9
Pune 9
Tappahannock 8
Salerno 7
Brescia 6
Jakarta 6
Napoli 6
Silver Spring 6
Tokyo 6
Wuhan 6
Zhengzhou 6
Bethesda 5
Buffalo 5
Chongqing 5
Hebei 5
Helsinki 5
Paris 5
San Diego 5
Seoul 5
Camporosso 4
Central District 4
Chicago 4
Fuzhou 4
Hong Kong 4
Lucca 4
Mexico 4
Padova 4
Pavia 4
Redmond 4
San Mateo 4
Shenyang 4
Singapore 4
University Park 4
Angers 3
Baotou 3
Belo Horizonte 3
Catania 3
Changchun 3
Chaoyang 3
Cuneo 3
Dallas 3
Des Moines 3
Detroit 3
Totale 6.018
Nome #
Nanoparticelle lipidiche solide per veicolare farmaci antitumorali oltre la barriera emato-encefalica, in particolare per il trattamento dei tumori cerebrali 455
Solid Lipid Nanoparticles for Potential Doxorubicin Delivery in Glioblastoma Treatment: Preliminary In Vitro Studies. 314
Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3-signalling. 290
WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma 238
Astroblastoma: Beside being a tumor entity, an occasional phenotype of astrocytic gliomas? 170
Solid lipid nanoparticles carrying temozolomide for melanoma treatment. Preliminary in vitro and in vivo studies 163
Mesenchymal/radioresistant traits in granular astrocytomas: Evidence from a combined clinical and molecular approach 135
Solid Lipid Nanoparticles Loaded with Antitumor Lipophilic Prodrugs Aimed to Glioblastoma Treatment: Preliminary Studies on Cultured Cells 126
Antigenic and genotypic similarity between primary glioblastomas and their derived neurospheres. 123
Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment 122
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells 120
Tumori cerebrali 119
Temozolomide down-regulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/GSK3/β-catenin pathway 118
Tumor cell proliferation and apoptosis in medulloblastoma 110
Parenchymal and Vascular Lesions in Ageing Equine Brains: Histological and Immunohistochemical Studies 110
Comparison of Allogeneic and Syngeneic Rat Glioma Models by Using MRI and Histopathologic Evaluation 105
SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy 99
bcl-2 protein expression in aged brain and neurodegenerative diseases. 98
A follow-up study of 60 cases of chronic spinal muscular atrophy 95
Motor neuron disease and malignancies: results of a population-based study 94
Experimental glioblastoma in Fisher rat model: treatment with a biocompatible system as carrier of methotrexate drug. 90
Histochemical studies on canine globoid cell leukodystrophy 88
Branched-chain amino acids and amyotrophic lateral sclerosis: a treatment failure? 88
A survival analysis of 155 cases of progressive muscular atrophy 86
Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis 85
Solid lipid nanoparticles as antineoplastic drugs vehicles in glioblastoma multiforme: in vitro and in vivo pathological effects. 84
Clinical-anatomic study of a family with bulbo-spinal muscular atrophy in adults 83
The prognostic role of vessel productive changes and vessel density in oligodendroglioma 81
Amyotrophic lateral sclerosis mortality in Italy, 1958 to 1987: a cross-sectional and cohort study 79
The significance of chondroitin sulfate proteoglycan 4 (CSPG4) in human gliomas 79
F-box protein Skp2 is not the only pathway for p27/Kip.1 degradation 77
CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas. 75
Reduced life expectancy in 40 cases of early onset cerebellar ataxia with retained tendon reflexes: a population-based study 74
Phenotypic and genotypic heterogeneity of dominantly inherited amyotrophic lateral sclerosis 74
Autosomal dominant multisystemic degeneration of nervous system with GDH-deficiency: a multidisciplinary study of a family 74
Krabbe’s disease in two West Higland White Terriers 73
Motor neuron disease in the province of Turin, Italy, 1966-1980. Survival analysis in an unselected population. 72
Cyclins and CDKs in oligodendroglioma progression 72
Motor neuron disease in the Province of Turin, Italy, 1971-1980 71
Methotrexate loaded SLN obtained by coacervation for potential glioblastoma treatment 70
Post-poliomyelitic motor neuron disease. Clinical aspects and its relation to typical motor neuron disease. 70
Risk of cancer in patients with Guillain-Barrè syndrome (GBS). A population-based study 69
Ubiquitin in motor neuron disease: study at the light and electron microscope 69
Experimental brain tumors by transplacental ENU. Multifactorial study of the latency period. 69
A cross sectional and cohort study of motor neurone disease in Piedmont, Italy 69
Hereditary motor and sensory neuropathies: a genetic and epidemiological study in the province of Turin, Italy 69
Glutamate dehydrogenase (GDH) deficiency in different types of progressive hereditary cerebellar ataxia 69
The vascular response to tumor infiltration in malignant gliomas. Morphometric and reconstruction study 68
Ubiquitinated dystrophic neurites suggest corticospinal derangement in patients with amyotrophic lateral sclerosis 68
Early onset cerebellar ataxia with retained tendon reflexes: prevalence and gene frequency in an Italian population 68
Progressive cerebellar ataxias: a clinical and genetic study of 52 index cases 68
p27/kip1 expression in oligodendrogliomas and its possible prognostic role. 67
Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma sets. 67
Serum creatine phosphokinase (CPK) levels in motor neuron disease: a predictive prognostic factor 67
SLN obtained by coacervation for potential anti-tumour drug delivery to the brain. 67
Primary lymphomas of the brain: a clinico-pathologic review of 37 cases 66
Distribution of activated caspase-3 in relation with apoptosis in human malignant gliomas. 65
Epidemiology of motor neuron disease in two Italian provinces. Analysis of secular trend and geographic distribution. 64
Glycosaminoglycans of brain tumors transplacentally induced by ENU in the rat. 64
Incidence of ALS in Italy: evidence for a uniform frequency in Western countries 64
Hereditary motor neuron disease: clinical, and genetic aspects of 13 families 64
Erratum: Muons in air showers at the Pierre Auger Observatory: Measurement of atmospheric production depth (Physical Review D - Particles, Fields, Gravitation and Cosmology (2014) 90 (012012) 64
Proliferative activity and prognosis of low-grade astrocytomas 63
Trends in Parkinson's disease mortality in Italy 63
Epidemiology of Duchenne muscular dystrophy in the province of Turin. 63
SEL1L plays a major role in human malignant gliomas 63
Prognostic value of histologic factors in adult cerebral astrocytoma 62
Glial fibrillary acidic protein and vimentin in the experimental glial reaction of the rat brain. 61
Survival analysis of motor neuron disese in a non-selected population 61
Analysis of mortality rates for amyotrophic lateral sclerosis (ALS) and Parkinson’s disease: evaluation 10 years later 61
Comparison among conventional and advanced MRI,18F-FDG PET/CT, phenotype and genotype in glioblastoma 61
Relationschip of PTEN mutations and EGFR amplification with p27 and cyclin D1 through Akt in glioblastomas 61
Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma 61
Amyotrophic lateral sclerosis among the migrant population to Piemonte, northwestern Italy. 61
Role of apoptosis in the prognosis of oligodendrogliomas 60
Reduced glutathione in amyotrophic lateral sclerosis: an open, crossover, randomized trial 60
Motoneuron disease and solvent and glue exposure 59
null 59
Prevalence of Parkinson's disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases. 58
Proliferating cell nuclear antigen (PCNA) in low-grade astrocytomas: its prognostic significance 57
Familial autosomal recessive rigid spine syndrome with neurogenic facio-scapulo-peroneal muscle atrophy. 57
Clinical and pathological findings in two familial cases of progressive muscular atrophy (PMA) 57
Cyclins, CDKs and their inhibitor p27/Kip.1 in normal and neoplastic oligodendroglia 57
Statistical analysis of prognostic factors in a series of oligodendrogliomas and oligoastrocytomas 56
Cell-cycle inhibitor p27/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumors. 55
Apoptosis in oligodendrogliomas as revealed by cleaved caspase-3,-7 and PARP immunohistochemistry 55
Glial fibrillary acidic protein (GFAP) in human cerebral tumors. An immunohistochemical study. 54
Apoptosis and cell proliferation in human neuroepithelial tumors 54
Free cytoplasmic Ca++ at rest and after cholinergic stimulus is increased in cultured muscle cells from Duchenne muscular dystrophy patients. 54
A study of prognostic factors in motor neuron disease 54
Histologic prognostic factors in ependymoma 54
Parkinson's disease mortality in Italy, 1951 through 1987. Analysis of an increasing trend 53
Collagenase in the immunohistochemical demonstration of laminin, fibronectin and factor VIII/RAg in nervous tissue after fixation. 53
Histological and immunohistochemical study of a neuroblastoma in a dog 53
Recurrencies in meningiomas 53
Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study 52
Glycosaminoglycans (GAGs) in human cerebral tumors. Part 1. Biochemical findings. 52
Amyotrophic lateral sclerosis among migrants to Piemonte, Italy, 1971-1990 52
Chronic spinal muscular atrophy in adults: a longitudinal study 52
Vascular response to irradiation in malignant gliomas 52
Totale 8.427
Categoria #
all - tutte 28.123
article - articoli 0
book - libri 0
conference - conferenze 6.625
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.748


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019364 0 0 0 0 0 0 0 0 0 82 216 66
2019/20201.457 50 74 111 113 107 208 185 100 182 180 87 60
2020/20211.196 136 42 113 70 122 84 91 43 181 99 67 148
2021/20221.387 25 41 46 122 39 54 119 69 47 146 317 362
2022/20232.117 243 114 52 180 246 577 177 123 217 63 83 42
2023/2024651 146 181 47 53 46 85 24 45 3 21 0 0
Totale 10.748